PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26401077-13 2015 AST, ALT and AFP levels in serum were significantly lower in the QHF, DDP and QHF plus DDP groups compared to the model control group (P < 0.05). Cisplatin 70-73 alpha fetoprotein Mus musculus 13-16 26515460-9 2015 Using a mouse xenograft model we could show a significant decrease of alpha-fetoprotein after combination therapy of oral micellar curcumin and cisplatin. Cisplatin 144-153 alpha fetoprotein Mus musculus 70-87 1370917-10 1992 The high AFP-titer strain (AFPGC-2) showed a marked regression or suppression of tumor growth after administration of both mitomycin C (MMC) and cisplatin (CDDP). Cisplatin 145-154 alpha fetoprotein Mus musculus 9-12 1370917-10 1992 The high AFP-titer strain (AFPGC-2) showed a marked regression or suppression of tumor growth after administration of both mitomycin C (MMC) and cisplatin (CDDP). Cisplatin 156-160 alpha fetoprotein Mus musculus 9-12 33685316-9 2021 Mice treated with cisplatin-loaded hydrogels exhibited a significant decrease in tumor growth, along with lower plasma AFP levels as compared to hydrogel-treated and untreated tumor-bearing mice. Cisplatin 18-27 alpha fetoprotein Mus musculus 119-122